BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 24576774)

  • 21. Usefulness of troponin T to predict short-term and long-term mortality in patients after hip fracture.
    Hietala P; Strandberg M; Kiviniemi T; Strandberg N; Airaksinen KE
    Am J Cardiol; 2014 Jul; 114(2):193-7. PubMed ID: 24856320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Urbano-Moral JA; Lopez-Haldon JE; Fernandez M; Mancha F; Sanchez A; Rodriguez-Puras MJ; Villa M; Lopez-Pardo F; Diaz de la Llera L; Valle JI; Martinez A
    Heart; 2012 Aug; 98(15):1153-9. PubMed ID: 22572051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postprocedural high-sensitivity troponin T and prognosis in patients with non-ST-segment elevation myocardial infarction treated with early percutaneous coronary intervention.
    Harada Y; Koskinas KC; Ndrepepa G; Räber L; Braun S; Zanchin T; Kufner S; Hunziker L; Byrne RA; Heg D; Kastrati A; Windecker S
    Cardiovasc Revasc Med; 2018 Jul; 19(5 Pt A):480-486. PubMed ID: 29292015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of high-sensitivity cardiac troponin T in acute ischemic stroke.
    Faiz KW; Thommessen B; Einvik G; Omland T; Rønning OM
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):241-8. PubMed ID: 23395473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in diagnosing non-ST-segment elevation myocardial infarction after the introduction of a new high-sensitivity cardiac troponin T assay: a single-centre experience.
    Hall TS; Hallén J; Agewall S; Atar D; Jensen T
    Clin Lab; 2012; 58(9-10):1029-36. PubMed ID: 23163120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of high-sensitivity troponin T levels in patients with ventricular arrhythmias and out-of-hospital cardiac arrest: data from the prospective FINNRESUSCI study.
    Røsjø H; Vaahersalo J; Hagve TA; Pettilä V; Kurola J; Omland T;
    Crit Care; 2014 Nov; 18(6):605. PubMed ID: 25490117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of quantitative troponin T measurements in unstable angina/non-ST-segment elevation acute myocardial infarction treated early and predominantly with percutaneous coronary intervention.
    Mueller C; Neumann FJ; Perruchoud AP; Zeller T; Buettner HJ
    Am J Med; 2004 Dec; 117(12):897-902. PubMed ID: 15629727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
    Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed versus immediate stenting for the treatment of ST-elevation acute myocardial infarction with a high thrombus burden.
    Ke D; Zhong W; Fan L; Chen L
    Coron Artery Dis; 2012 Nov; 23(7):497-506. PubMed ID: 22968214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated baseline cardiac troponin levels in the elderly - another variable to consider?
    Webb IG; Yam ST; Cooke R; Aitken A; Larsen PD; Harding SA
    Heart Lung Circ; 2015 Feb; 24(2):142-8. PubMed ID: 25168154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy.
    Fröhlich GM; Schoch B; Schmid F; Keller P; Sudano I; Lüscher TF; Noll G; Ruschitzka F; Enseleit F
    Int J Cardiol; 2012 Feb; 154(3):328-32. PubMed ID: 22044675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of MI after CABG with high-sensitivity troponin T and new ECG or echocardiogram changes: relationship with mortality and validation of the universal definition of MI.
    Wang TK; Stewart RA; Ramanathan T; Kang N; Gamble G; White HD
    Eur Heart J Acute Cardiovasc Care; 2013 Dec; 2(4):323-33. PubMed ID: 24338291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble form of membrane attack complex independently predicts mortality and cardiovascular events in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Mogelvang R; Galatius S; Flyvbjerg A; Jensen JS; Bjerre M
    Am Heart J; 2012 Nov; 164(5):786-92. PubMed ID: 23137511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of high-sensitivity troponin T for the evaluation of patients with acute chest pain and no or minimal myocardial damage.
    Sanchis J; Bardají A; Bosch X; Loma-Osorio P; Marín F; Sánchez PL; Núñez J; Carratalá A; Barrabés JA
    Am Heart J; 2012 Aug; 164(2):194-200.e1. PubMed ID: 22877804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of patients with acute myocardial infarction from a saphenous vein graft culprit undergoing percutaneous coronary intervention.
    Gaglia MA; Torguson R; Xue Z; Gonzalez MA; Ben-Dor I; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):23-9. PubMed ID: 21061247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention.
    Schoos MM; Kelbæk H; Kofoed KF; Køber L; Kløvgaard L; Helqvist S; Engstrøm T; Saunamäki K; Jørgensen E; Holmvang L; Clemmensen P
    Am J Cardiol; 2011 Jun; 107(11):1597-603. PubMed ID: 21439539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.